There’s a new mystery unfolding online regarding birth control (like Yaz!), and reading it could save your life or the life of someone you know.
Read More »Author: Amelia Murphy
Foremother and Health Policy Hero Awards Luncheons
NCHR Testimony at the FDA about a Drug for Opioid Withdrawal Symptoms, Lofexidine
March 27, 2018. Patients undergoing opioid withdrawal need non-opioid effective treatment alternatives. In order to ensure the we are doing more good than harm, the FDA must ensure that treatments show substantial evidence of effectiveness. Current data indicate that lofexidine can successfully provide short-term relief of patients’ opioid withdrawal symptoms following abrupt discontinuation. However, due to cardiac safety risks, this drug should not be indicated for individuals with existing cardiac conditions, and if approved, there should be a clear warning on the drug’s label. Finally, the sponsor has not provided sufficient evidence that lofexidine increases the likelihood that individuals will complete withdrawal treatment and, ultimately, move toward ending their physical dependence on opioids. We believe they must do so in order to receive this indication.
Read More »Reducing Opioid Doses: A Promising Strategy to Combat the Opioid Crisis
What can we learn from this study? It shows that it is possible to help patients who are taking daily opioids to reduce their opioid dose in a community pain clinic with one doctor’s help and a self-help book.
Read More »Beginner’s Guide to Developing an Exercise Routine
Exercise is one of NCHR’s seven recommended ways to maximize your health. If you want to exercise but aren’t sure where to begin, we can help! If you feel like your daily life doesn’t allow you to get fit (not enough time, no money for a gym membership, etc.), we have some “work-arounds” that may help.
Read More »